Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in New-Onset Type 1 Diabetes: A Multicenter Analysis
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes (T1D) is one of the major autoimmune diseases affecting children and young adults worldwide. To date, the different immunotherapies tested have achieved insulin independence in <5% of treated individuals. Recently, a novel hematopoietic stem cell (HSC)–based strategy has been tested in individuals with new-onset T1D. The aim of this study was to determine the effects of autologous nonmyeloablative HSC transplantation in 65 individuals with new-onset T1D who were enrolled in two Chinese centers and one Polish center, pooled, and followed up for 48 months. A total of 59% of individuals with T1D achieved insulin independence within the first 6 months after receiving conditioning immunosuppression therapy (with antithymocyte globulin and cyclophosphamide) and a single infusion of autologous HSCs, and 32% remained insulin independent at the last time point of their follow-up. All treated subjects showed a decrease in HbA1c levels and an increase in C-peptide levels compared with pretreatment. Despite a complete immune system recovery (i.e., leukocyte count) after treatment, 52% of treated individuals experienced adverse effects. Our study suggests the following: 1) that remission of T1D is possible by combining HSC transplantation and immunosuppression; 2) that autologous nonmyeloablative HSC transplantation represents an effective treatment for selected individuals with T1D; and 3) that safer HSC-based therapeutic options are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“one study reported severe infections in T1D patients after the stem cell therapy.319,322–324”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [322]
In the citing paper
“However, there have been inconsistencies with these findings generated in other studies”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [322]
Citations
Cites
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60886-6 · Cited by 612
Voltarelli, J. C., Couri, C. E. B., Stracieri, A. B. P. L., Oliveira, M. C., Moraes, D. A., Pieroni, F., Coutinho, M., Malmegrim, K. C. R., Foss-Freitas, M. C., Simões, B. P., et al. (2007) · JAMA · doi:10.1001/jama.297.14.1568 · Cited by 573 · cited 1×
“(10) succeeded in exploiting hematopoietic stem cells (HSCs) to treat new-onset T1D and achieved encouraging results, paving the way for another three trials, which were initiated worldwide (11,12).”
Sherry, N., Hagopian, W., Ludvigsson, J., Jain, S. M., Wahlen, J., Ferry, R. J., Bode, B., Aronoff, S., Holland, C., Carlin, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60931-8 · Cited by 493
Shah, S. C., Malone, J., & Simpson, N. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200902 · Cited by 317
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Herold, K. C., Vignali, D. A. A., Cooke, A., & Bluestone, J. A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3422 · Cited by 237
The Clinical Impact of Islet Transplantation
Fiorina, P., Shapiro, A. M. J., Ricordi, C., & Secchi, A. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02353.x · Cited by 224
Self-citationRachamim, N., Gan, J., Segall, H., Krauthgamer, R., Marcus, H., Berrebi, A., Martelli, M., & Reisner, Y. (1998) · Transplantation · doi:10.1097/00007890-199805270-00017 · Cited by 180
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans
Fadini, G. P., Albiero, M., Vigili de Kreutzenberg, S., Boscaro, E., Cappellari, R., Marescotti, M., Poncina, N., Agostini, C., & Avogaro, A. (2013) · Diabetes Care · doi:10.2337/dc12-1084 · Cited by 177
Cited by
Items 101–162 of 162
Jamiołkowska‐Sztabkowska, M., Grubczak, K., Starosz, A., Krętowska-Grunwald, A., Krętowska, M., Parfienowicz, Z., Moniuszko, M., Bossowski, A. T., & Głowińska‐Olszewska, B. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10250-7 · Cited by 9
Updates on Immune Therapies in Type 1 Diabetes
Nambam, B., & Haller, M. J. (2016) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2016.12.02.89 · Cited by 8
Sustaining Brain Youth by Neural Stem Cells: Physiological and Therapeutic Perspectives
dos Santos, M. A., Moreira, J. A. F., Santos, S. S., & Solá, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04774-z · Cited by 8
Zhang, S., Dai, Q., Zhang, B., Liu, S. M., Wang, Y., Zhang, Y., Chen, D., Zong, N., Wang, H., Ding, J., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3329 · Cited by 7
Xiang, H., Zhang, X., Yang, C., Xu, W., Ge, X., Zhang, R., Qiu, Y. F., Sun, W.-J., Li, F., Xiang, T., et al. (2016) · Frontiers of Medicine · doi:10.1007/s11684-016-0485-4 · Cited by 7
Pharmacologic targeting of the diabetic stem cell mobilopathy
Albiero, M., & Fadini, G. P. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.017 · Cited by 8
Current Challenges in Pancreas and Islet Transplantation: A Scoping Review
Altabas, V., & Bulum, T. (2024) · Biomedicines · doi:10.3390/biomedicines12122853 · Cited by 6
Prevention of Type 1 Diabetes: Current Perspective
Pande, A. K., Dutta, D., & Singla, R. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_78_23 · Cited by 6
Novel therapies for T1D on the horizon
Nasr, M. B., & Fiorina, P. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.019 · Cited by 6
Self-citationImmunomodulatory agents and cell therapy for patients with type 1 diabetes
Rodacki, M., Silva, K. R., Araújo, D. B., Dantas, J. R., Ramos, M. E. N., Zajdenverg, L., & Baptista, L. S. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2024-0233 · Cited by 6
Tootee, A., Nasli‐Esfahani, E., Ghodsi, M., Razi, F., Amini, M., Larijani, B. A., & Heshmat, R. (2015) · Iranian Journal of Public Health · Cited by 5
Nasr, M. B., Robbins, D., Parone, P. A., Usuelli, V., Tacke, R., Seelam, A. J., Driver, E., Le, T. M., Sabouri-Ghomi, M., Guerrettaz, L., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100949 · Cited by 6
Self-citationRebalancing the Immune System to Treat Type 1 Diabetes
Müller, Y. D., Ho, P., Bluestone, J. A., & Tang, Q. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041599 · Cited by 5
Cell Therapies and Gene Therapy for Diabetes: Current Progress
Ghassemifard, L., Hasanlu, M., Parsamanesh, N., Atkin, S. L., Almahmeed, W. A., & Sahebkar, A. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998292392240425122326 · Cited by 4
Regmi, S., Pathak, S., Chaudhary, D., Kim, J. O., Nam, J., Kim, H., Jiang, H., Ryu, D., Sung, J.-H., Yook, S., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03777-2 · Cited by 4
CXCR4 antagonism overcomes diabetic stem cell mobilopathy
Nasr, M. B., & Fiorina, P. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.025 · Cited by 4
Self-citationGhodsi, M., Abbasi, F., Tootee, A., Heshmat, R., Rambod, C., & Larijani, B. A. (2015) · Iranian Journal of Public Health · Cited by 4
Melve, G. K., Ersvær, E., Akkök, Ç. A., Ahmed, A. B., Kristoffersen, E. K., Hervig, T. A., & Bruserud, Ø. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071158 · Cited by 4
D’Addio, F., Nasr, M. B., Lunati, M. E., & Fiorina, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00075-8 · Cited by 3
Self-citationNext-gen therapeutics to spare and expand beta-cell mass
Bolla, A. M., Usuelli, V., Nasr, M. B., Frigerio, S., Loretelli, C., D’Addio, F., & Fiorina, P. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.09.001 · Cited by 3
Self-citationSkyler, J. S. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_15-1 · Cited by 4
Lu, J., Shen, S., Ling, Q., Zhang, W. Y., Qu, D., Wang, B., Bi, Y., & Zhu, D. (2020) · Research Square · doi:10.21203/rs.3.rs-115774/v1 · Cited by 3
Self-citationConcise review: Hematopoietic stem cell transplantation to treat insulin-dependent diabetes mellitus
Bui, A. T.-V., & Pham, P. V. (2017) · Progress in Stem Cell · doi:10.15419/psc.v4i2.381 · Cited by 2
Nursing interventions in autologous stem cell transplantation for autoimmune diseases
Nilsen, L., dos Santos, B. N., Leopoldo, V. C., dos Reis, P. E. D., Oliveira, M. C., Clark, A. M., & Silveira, R. C. D. C. P. (2020) · Journal of Advanced Nursing · doi:10.1111/jan.14559 · Cited by 1
An overview of stem cell application in regenerative medicine
Riaz, F., Asgharzadeh, F., Binabaj, M. M., Ghalami, S., Saeinasab, M., & Sefat, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34152-6.00004-4 · Cited by 1
Stem cell therapies for treatment of diabetes mellitus
Guo, F., Song, Y., & Qin, G. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004150 · Cited by 1
Arruda, L. C. M., Oliveira, M. C., Malmegrim, K. C. R., Gluckman, É., & Farge, D. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.058 · Cited by 1
Prolonged type 1 diabetes honeymoon period: Case report and review of the literature
Mahzari, M. M. (2020) · King Khalid University Journal of Health Sciences · doi:10.4103/kkujhs.kkujhs_23_20 · Cited by 1
Traynard, V. (2020) · HEGEL - HEpato-GastroEntérologie Libérale · doi:10.3917/heg.102.0118 · Cited by 1
Effectiveness and safety of stem cells in the treatment of diabetes
Ткач, С. М., & Pankiv, V. І. (2022) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.18.8.2022.1225 · Cited by 1
Sulaiman, S. A., Alaarag, A., Rayyan, N., Tuffaha, Y., Al‐Awamleh, N. A., & Dojan, K. A. A. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-025-00908-4 · Cited by 2
Editorial: The Role of Hematopoietic Progenitors in Immune Regulation and Memory
Zavala, F., Nombela‐Arrieta, C., Nasr, M. B., & Fiorina, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.789139 · Cited by 1
Self-citationHalfon, M., Rotman, S., Egli, M., Venetz, J.-P., & Pascual, M. A. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0787-z
Autogreffe de cellules souches hématopoïétiques
Costello, R. T., Venton, G., Colle, J., Farnault, L., & Poullin, P. (2015)
Hematopoietic Cell Transplants for Non-Neoplastic Diseases
Abutalib, S. A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.053
Current and Future Approaches to Stem Cell Treatment of Type I Diabetes
Yacoub, M. H., Webert*, M., Lindberg, M. R., & Viola, M. (2018) · Georgetown Medical Review · doi:10.52504/001c.3217
Cooper, T. T., Bell, G. I., & Hess, D. A. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0111 · Cited by 1
Skyler, J. S. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch37
Traynard, V. (2020) · HEGEL - HEpato-GastroEntérologie Libérale · doi:10.3917/heg.104.0365
Stem Cell Therapy in Treating Type 1 Diabetes Mellitus –Potential and Ethical Issues.
Abdullah, N., & Elias, M. (2021) · Malaysian Journal of Science Health & Technology · doi:10.33102/mjosht.v6i.122
Traynard, V. (2021) · HEGEL - HEpato-GastroEntérologie Libérale · doi:10.3917/heg.111.0037
Trends of Stem Cell-Based Clinical Trials in Gastrointestinal Tract Diseases
Jabbarpour, Z., Ghahremani, M. H., Saidijam, M., Kiani, J., & Ahmadbeigi, N. (2021) · Journal of Analytical Oncology · doi:10.30683/1927-7229.2020.09.07
Skyler, J. S. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_15 · Cited by 1
Manuscripts Reviewed for the 2014 Yearbook
(2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.1515
Alzahrani, A. Y. B., Alghamdi, L. S. A., Alnashi, S., & Alghamdi, A. H. (2022) · Journal of Vaccines Immunology and Immunopathology · doi:10.29011/2575-789x.000183
The Application of Stem Cell Therapy on Type 1 Diabetes
Huang, X., & Ma, G. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v54i.9758
Madani, S., Amanzadi, M., Aghayan, H. R., Setudeh, A., Rezaei, N., Rouhifard, M., & Larijani, B. (2022) · Figshare · doi:10.6084/m9.figshare.19695788
Lu, J., Shen, S.-M., Ling, Q., Wang, B., Li, L.-R., Zhang, W., Qu, D.-D., Bi, Y., & Zhu, D.-L. (2021) · Figshare · doi:10.6084/m9.figshare.14767146
Self-citationLu, J., Shen, S.-M., Ling, Q., Wang, B., Li, L.-R., Zhang, W., Qu, D.-D., Bi, Y., & Zhu, D.-L. (2021) · Figshare · doi:10.6084/m9.figshare.14767143
Self-citationRegmi, S., Pathak, S., Chaudhary, D., Kim, J. O., Nam, J.-W., Kim, H.-S., Jiang, H.-L., Ryu, D., Sung, J.-H., Yook, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26036377
Lu, J., Shen, S.-M., Ling, Q., Wang, B., Li, L.-R., Zhang, W., Qu, D.-D., Bi, Y., & Zhu, D.-L. (2021) · Figshare · doi:10.6084/m9.figshare.14767140
Self-citationMadani, S., Amanzadi, M., Aghayan, H. R., Setudeh, A., Rezaei, N., Rouhifard, M., & Larijani, B. (2022) · Figshare · doi:10.6084/m9.figshare.19695773
Madani, S., Amanzadi, M., Aghayan, H. R., Setudeh, A., Rezaei, N., Rouhifard, M., & Larijani, B. (2022) · Figshare · doi:10.6084/m9.figshare.19695770
Spadini, S. (n.d.) · Padua Research Archive (University of Padova)
A Novel Autoimmune Presentation of Wiskott‐Aldrich Syndrome: Type 1 Diabetes
Rayan, M. N., Alshawabkeh, Y., Zia, S., & Ghalib, L. M. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70329
Cell Therapy for Type 1 Diabetes Mellitus
Ghoneim, M. A., Refaie, A. F., & Gabr, M. M. (2026) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-032-12705-1_6
Approches thérapeutiques métaboliques et immunologiques des leucémies aiguës myéloïdes
Venton, G. (2016) · theses.fr (ABES) · doi:10.70675/2b894d94zf035z47d5zbf3dzcf524b6bbe5a
Hasna, I. H., Suprijadi, I. A. S., Khaerunnisa, S., Larasati, V., & Al-Khazaleh, A. K. (2026) · Biomolecular and Health Science Journal · doi:10.4103/bhsj.bhsj_13_26
Lyu, C., Chen, Z., & Zhao, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1895856 · Cited by 1
Making space for cures: Conditioning for autologous hematopoietic stem cell gene therapies
Crees, Z. D., DiPersio, J. F., & Persaud, S. P. (2026) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.09.001
Study of Antithymocyte Globulin for Treatment of New-onset T1DM (START)
Gitelman, S. (2020) · ImmPort · doi:10.21430/m39q379sfj
Metadata
- Authors
- D’Addio, F., Valderrama Vasquez, A., Ben Nasr, M., Franek, E., Zhu, D., Li, L., Ning, G., Snarski, E., & Fiorina, P.
- Affiliations
- Boston Children's Hospital (US)
- Transplant Medicine, IRCCS San Raffaele Hospital, Milan, Italy
- Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA
- Ministry of Interior and Administration (PL)
- Nanjing Drum Tower Hospital (CN)
- Shanghai Jiao Tong University (CN)
- Medical University of Warsaw (PL)
- Corresponding author
- Fiorina, Paolo
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-08-16
- Volume
- 63
- Issue
- 9
- Pages
- 3041-3046
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2147402097
- Cited by
- 160
- References
- 26
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 13 · 2021: 21 · 2020: 13 · 2019: 4 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 19 · 2014: 4
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- type 1 diabetes, autologous stem cell transplantation, nonmyeloablative conditioning, antithymocyte globulin, cyclophosphamide, insulin independence, remission, C-peptide, HbA1c, immune reconstitution, adverse effects
- MeSH terms
- Adolescent, Adult, C-Peptide, Child, Cyclophosphamide, Diabetes Mellitus, Type 1, Female, Humans, Immunosuppression Therapy, Insulin, Male, Remission Induction, Transplantation, Autologous, Hematopoietic Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.